DCF — LUTHERAN MEDICAL CENTER
Enterprise Value: $-906.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-906.7M
Enterprise Value
$-281.5M
PV of Cash Flows
$-625.1M
PV of Terminal Value
$-1.0B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $409.3M | $-59.4M | -15.0% | $-76.7M | $-69.7M |
| Year 2 | $421.6M | $-56.9M | -14.0% | $-74.8M | $-61.8M |
| Year 3 | $434.3M | $-54.3M | -13.0% | $-72.7M | $-54.6M |
| Year 4 | $447.3M | $-53.7M | -12.0% | $-72.6M | $-49.6M |
| Year 5 | $460.7M | $-54.2M | -12.0% | $-73.7M | $-45.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-906.7M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$397.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.15007181078683077
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5